¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"mean cell volume"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
blood cell
Ç÷¾×¼¼Æ÷, Ç÷±¸
blood cell separator
Ç÷±¸ºÐ¸®±â
bone marrow-derived cell
°ñ¼öÀ¯·¡¼¼Æ÷
border cell
°æ°è¼¼Æ÷, ¼Ó°æ°è¼¼Æ÷
balloon cell
dz¼±¼¼Æ÷
balloon cell nevus
dz¼±¼¼Æ÷¸ð¹Ý
bristle cell
¾ï¼¾Åм¼Æ÷, °¸ð¼¼Æ÷
burr cell
¹«µòÅ鳯ÀûÇ÷±¸
ciliated cell
¼¶¸ð¼¼Æ÷
clear cell
Åõ¸í¼¼Æ÷
clear cell acanthoma
Åõ¸í¼¼Æ÷°¡½Ã¼¼Æ÷Á¾, Åõ¸í¼¼Æ÷±Ø¼¼Æ÷Á¾
clear cell adenocarcinoma
Åõ¸í¼¼Æ÷»ù¾ÏÁ¾, Åõ¸í¼¼Æ÷¼±¾ÏÁ¾
clear cell carcinoma
Åõ¸í¼¼Æ÷¾ÏÁ¾
clear cell hidradenoma
Åõ¸í¼¼Æ÷¶¡»ùÁ¾
clear cell sarcoma
Åõ¸í¼¼Æ÷À°Á¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
basal cell adenoma
±âÀú¼¼Æ÷»ùÁ¾, ¹Ù´Ú¼¼Æ÷¾ÏÁ¾
basosqumaous cell acanthoma
±âÀúÆíÆò¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
cell-associated antibody
¼¼Æ÷ºÎÂøÇ×ü
cell-bound antibody
(¢¡cell-fixed antibody) ¼¼Æ÷°áÇÕÇ×ü
cell-fixed antibody
¼¼Æ÷°áÇÕÇ×ü
clear cell acanthoma
Åõ¸í¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
clear cell adenocarcinoma
Åõ¸í¼¼Æ÷»ù¾ÏÁ¾
crescent cell anemia
Ãʽ´ÞÀûÇ÷±¸ºóÇ÷
helper cell activity
µµ¿ò¼¼Æ÷´É, Á¶·Â¼¼Æ÷´É
islet cell adenoma
¼¶¼¼Æ÷»ùÁ¾
large cell acanthoma
Å«¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
red cell aplasia
ÀûÇ÷±¸¹«Çü¼º
sickle cell anemia
³´ÀûÇ÷±¸ºóÇ÷
subependymal giant cell astrocytoma
³ú½Ç¸·¹Ø°Å´ë¼¼Æ÷º°¼¼Æ÷Á¾, »óÀÇÇϰŴ뼼Æ÷º°¼¼Æ÷Á¾
target cell anemia
Ç¥ÀûÀûÇ÷±¸ºóÇ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
RDW=> red cell distribution width
ÀûÇ÷±¸ºÐÆ÷Æø
Raji cell assay
¶óÁö¼¼Æ÷½ÃÇè
Reed-Sterberg cell
¸®À̵å-½ºÅ׸¥º£¸£±× ¼¼Æ÷
Schwann cell tumor
½´¹Ý¼¼Æ÷Á¾¾ç
Schwann s cell
½´¹Ý¼¼Æ÷.
Sertoli cell
½áÅ丮 ¼¼Æ÷
Sertoli cell only syndrome
½áÅ丮 ¼¼Æ÷ ÁõÈıº
Sezary cell
¼¼ÀÚ¸®¼¼Æ÷
T cell ; T lymphocyte ; thymus derived lymphocyte
T¼¼Æ÷ ; T¸²ÇÁ? ; Èä¼±À¯·¡¸²ÇÁ?
T cell activating factor
T¼¼Æ÷Ȱ¼ºÀÎÀÚ
T cell cooperation
T¼¼Æ÷Çùµ¿
T cell deficiency
T¼¼Æ÷°áÇÌ
T cell factor (TCF)
T¼¼Æ÷
T cell growth factor (TCGF, IL-2)
T¼¼Æ÷ Áõ½ÄÀÎÀÚ
T cell hybridoma
T¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
expiratory reserve volume =ERV
È£½Ä¼º ¿¹ºñ¿ëÀû(û¼ãÓàõçãÝáé»îÝ). ¸¶ Ãë È£±â¿¹ºñ·®, ¿¹ºñÈ£±â
expiratory reserve volume =ERV
È£±â¿¹ºñ·®, ¿¹ºñÈ£±â·®, È£½Ä¼º ¿¹ºñ¿ëÀû
extracellular liquid volume
¼¼Æ÷¿Ü¾×·®(¡äûåÖ).
flow volume curve
À¯·®¿ë·®°î¼±(êüÕáé»ÕáÍØàÊ).
flow-volume curve
forced expiratory volume
°Á¦È£±â(ÆóȰ)·®, ³ë·ÂÈ£±âÆóȰ·®
forced expiratory volume = FEV
°Á¦È£±â(ÆóȰ)·®, ³ë·ÂÈ£±âÆóȰ·®
forced expiratory volume =FEV
°Á¦È£±â(ÆóȰ(øËüÀ))·®, ³ë·ÂÈ£±âÆóȰ·®(Ò½æ³ û¼Ñ¨øËüÀåÖ).
forced expiratory volume =FEV
°Á¦È£±â(ÆóȰ)·®, ³ë·ÂÈ£±âÆóȰ·®
forced inspiratory volume =FIV
<ÃÖ´ë>³ë·ÂÈí±âÆóȰ·®(<õÌÓÞ>Ò½æ³ýåѨøËüÀåÖ).
forced inspiratory volume =FIV
<ÃÖ´ë>³ë·ÂÈí±âÆóȰ·®(<õÌÓÞ>Ò½æ³
gross tumor volume, GTV
À°¾ÈÀûÁ¾¾çüÀû
high volume sampler
ÇÏÀ̺¼·ý»ùÇ÷¯.
inspiratory reserve volume
Èí½Ä(¼º)¿¹ºñ¿ëÀû(ýåãÓàõçãÝáé»îÝ), Èí±âÀܱⷮ( ¡íÑѨåÖ).
inspiratory triggering volume
Èí±âÀ¯¹ß·®.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½